Erzurum yöresinde üst solunum yolu enfeksiyonlu hastalarda bazı viral etkenlerin araştırılması

Bu çalışmada, hücre kültürü yöntemi ile üst solunum yollarında infeksiyon oluşturan İnfluenzavirus, Adenovirus (ADV), Parainfluenzavirus, Respiratory Syncytial Virus (RSV) saptanması ve Erzurum yöresindeki prevalansının belirlenmesi amaçlandı. Araştırmada 97’si (%56.7) yetişkin, 74’ü (%43.3) çocuk olmak üzere toplam 171 hastaya ait nazofaringeal swap örneği kullanıldı. Yetişkin örnek grubunun 49’unu (%50.5) erkekler, 48’ini ise (%49.5) kadınlar oluştururken, çocuk örnek grubunun 33 adedini (%44.6) erkek çocuklar, 41 adedini de (%55.4) kız çocuklar oluşturmaktaydı. Çalışma sonucunda hiçbir numunede Parainfluenza virusuna rastlanmazken, 27 örnekte (10 çocuk, 17 erişkin; %15.8) İnfluenzavirus A, 11 örnekte (10 çocuk, 1 erişkin; %6.4) ADV, 7 örnekte (6 çocuk, 1 erişkin; %4.1) RSV ve 5 örnekte de (4 çocuk, 1 erişkin; %2.9) İnfluenzavirus B tespit edildi. Kuş gribi (H5N1) şüpheli bir çocuk hastada da Real Time PCR yöntemi ile Roboscreen RoboGene H5N1 hazır ticari kiti ile RNA araştırılması yapıldı ve hastada H5N1 nükleik asidi tespit edildi Ayrıca marazi maddelerin MDCK (İnfluenzavirus A-B) ve Hep-2 (RSV, ADV) hücrelerine ekimleri yapılarak Immun floresans antikor yöntemi ile viral etkenlerin varlığı araştırıldı. Viral etkenler arasında en fazla İnfluenzavirus A saptanırken, en az İnfluenzavirus B tespit edildi. Çalışmamızda hastaların yaş grupları ve cinsiyetler arasında viral ajan görülme oranları bakımından istatistiksel bir fark bulunamadı.

The investigation of some viral agents in the patients with upper respiratory tract in Erzurum region

In this study, we aimed to determine the prevalance of Respiratory Syncytial Virus, Parainfluenza and Adenovirus leading to infection and influenza in upper respiratory tract by means of cell culture method. In the study, samples belonging to total 171 patients, 97 of whom are adults (56.7%) and 74 of whom are children (43.3%) were used. While 49 of adult sampling group were male (50.5%), 48 of them were female (49.5%), and children sampling group consisted of 33 male (44.6%) and 41 female (55.4%). In the conclusion of the study, while parainfluenza virus couldnt be observed, there was Influenza A in 27 samples (10 children, 17 adults; 15.8%), and there was Adenovirus (ADV) in 11 samples (10 children and 1 adult; 6.4%), and there was Respiratory Syncytial Virus (RSV) in seen 7 samples (6 children and 1 adult; 4.1%) and there was Influenza B virus in 5 samples (4 children and 1 adult; 2.9%) and H5N1 Bird Flu Virus was detected in a patient by means of Real Time PCR method. By means of Roboscreen RoboGene H5N1 Ready-Commercial Kit, RNA investigation was carried out ın one sample (a children) H5N1 virus was detected. After planting for MDCK and Hep-2 cells, and by using direct immunoflourescence (IFA) method in order for cytopotic effects to be devided, virus agents were detected. By means of cell culture, Influenza A and B were produced in MDCK cells, and RSV and ADV were produced in Hep-2 cells. Among viral agents, while Influenza A was detected the most, Influenza B was found the least. In our study, we couldnt find a distinction in the rates of viral agents prevalence according to age and genders of the patients by means of chi-square method.

___

  • 1. Aymard M, Valette M, Lina B, Thouvenot D: Surveillance and impact of influenza in Europe. Vaccine, 17 (1): 3041,1999. 2. Bozkaya E, Çungurlu AS: Geçmişten günümüze solunum yolu infeksiyon salgıları ve sars. Hipokrat Derg, 12, 245250, 2003. 3. Ballenger JJ, Snow JB: The clinical anatomy and physiology of nose and paranasal sinuses. In, Ballenger JJ, Snow JB (Eds): Otorhinolaryngology: Head and Neck Surgery. 15th ed., pp. 3-18, Philadelphia, Lippincott, 2000. 4. Hodes DS: Respiratory Infections and Sinusitis. In, Katz SL, Gershon AA, Hotez PJ (Eds): Krugman’s Infectious Diseases of Children. 10th ed., pp. 362-401. St. Luis, Mosby, 1998. 5. Raphael GD, Barabjuk JN, Kaliner MA: How and why the nose runs? J Allergy Clin Immunol, 87 (2): 457-460,1991. 6. Gwaltney JM: The Common Cold. In, Mandell GL, Bennet JE, Dolin R (Eds): Principles and Practice of Infectious Diseases. Vol. I, Section B - Upper Respiratory Tract Infections. 5th ed., pp. 676-686, C. Livingstone, Philedelphia, 2000. 7. Smith W, Andrewes CH, Laidlaw PP: A virus obtained from Influenza patients. Lancet, 2, 66-68,1936. 8. Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L: Adverse effects of aspirin, acetaminophen, and ibuprofen or immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis, 162 (6): 12771282,1990. 9. Önalan A, Arslan S, Bozkaya E, Badur S: Türkiye’de 20032004 ve 2004-2005 yıllarında grip sürveyansn ve izole edilen Influenza virus suşlarının tiplendirimi. KLİMİK Derg, 19 (1): 39, 2006. 10. Mc Agree KG: The use of cultured epithelial autografts in the wound care of severly burned patient. J Pediatr Surg, 28 (2): 166-168, 1993. 11. Poot A: Dependence of endothelial cell growth on sunsrate-bound fibronectin. Clinical Materials, 11, 151-155, 1992. 12. SPSS: SPSS for Windows, SPSS Copyright Ins, Versiyon 10.0, 1999. 13. Özdamar M, Türkoğlu S, Hakko E, Tahmaz EF: İstanbul ve Kocaeli’nde Influenza prevalansının hızlı antijen testi ile belirlenmesi. ANKEM Derg, 21, 51-52, 2007. 14. Önlen Y, Duran N, Savaş L, İncecik F, Taş S: Antakya’da 0-15 yaşları arasındaki ÜSYE şüpheli çocuklarda Influenza A ve Influenza B virusu seroprevalansı. KLİMİK Kongre Kitabı, 21, 315, 2005. 15. Yarkın F, Alhan E, Kibar F, Karabay A, Köksal F: Pediatrik popülasyonunda viral altsolunum yolu enfeksiyonlarnnnn insidansn. 25. Türk Mikrobiyoloji Kongresi Kitabn, s. 225, Antalya, 1994. 16. Arslan S, Önal A: Türkiye’de 2002-2003 knş mevsiminde influenza virusu sürveyans araştnrmasn. [http://www.gribeson. son/ovepimages/Flusurveyans2003-2003Turkey.pdf]. Erişim tarihi: 22.03.2009 17. Kaygusuz S, Koksal I, Aydin K, Caylan R: Investigation of atypical bacteria and virus antigens in respiratory tract infections by use of nmmunofluorescence metod. Jpn J Infect Dis, 57, 33-36, 2004. 18. CDC: Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 53 (6): 1-40, 2004. 19. CDC: Weekly Report: Influenza Summary Update Week ending November 29, 2003-Week 48. [http://www.cdc.gov/ flu/weekly/weeklyarchives2004-2005/weekly48.htm]. Accessed: 08.03.2009. 20. WHO: Collaborating Centre for Reference and Research on Influenza, London: August 2003 to July 2004. [http://www. who.int/wer], Accessed: 10.10.2005. 21. WHO: Addendum to the recommended composition of influenza virus vaccines for use in the 2003-2004 influenza season. Weekly Epidemiol Rec, 78, 73-80, 2003. 22. Çelikbaş AK, Ymlmaz N, Ulu A, Ergönül Ö, Dokuzoğuz B, Kara Ş, Toprak S: Üst solunum yolu infeksiyonlarnnda viral etkenlerin araştnrnlmasn. İnfeksiyon Derg, 19 (3): 377-380, 2005. 23. WHO: Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. Weekly Epidemiol Rec, 80, 71-76, 2005. 24. Meerhoff TJ, Paget WJ, Aguilera J-F, van der Velden J: Harmonising the virological surveillance of influenza in Europe: Results of an 18-country survey. Virus Res, 103, 3133, 2004 25. Nicholson KG, McNally T, Silverman M, Simons P, Stockton JD, Zambon MC: Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumo virus among infants and young children. Vaccine, 24 (1): 102108, 2006. 26. Liebermen D, Karsonsky I, Yaakov MB, Lazorovich Z, Friedman MG, Dvoskin B, Leinonen M, Ohana B, Boldur I: A comperative study of the etiology of adult upper and lower respiratory tract infections in the community. Diag Microbiol Infect Dis, 42, 21-28, 2002. 27. Martio R, Ramila E, Rabella N, Munoz JM, Peyret M, Portos JM, Laborda R, Sierra J: Respiratory virus infections in adults with haematologic malingnancies, a prospective study. Clin Infect Dis, 36, 1-8, 2003. 28. Holmberg H: Aetiology of community-acquired pneumonia in hospital treated patients. Scand J Infect Dis, 19, 491-501, 1987.